Loading publications…
The last 5 uploaded publications
Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer
Martin Förster, Konstantin J. Dedes, Shahneen Sandhu, Sophia Frentzas, Rebecca Kristeleit, Alan Ashworth, Christopher Poole, Britta Weigelt, Stan B. Kaye, L Rhoda Molife (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. , 8(5), DOI: https://doi.org/10.1038/nrclinonc.2011.42.
Article62 days ago1258 Changing perceptions of oncologists referring advanced colorectal (ACRC) patients (pts) to phase 1 trials: an evidence based approach
André T. Brunetto, D.S.W. Tan, David Olmos, Tami Yap, Sophia Frentzas, Shahneen Sandhu, Katie Ann Denholm, Bee Ayite, Johann S. de Bono, S.B. Kaye (2009). 1258 Changing perceptions of oncologists referring advanced colorectal (ACRC) patients (pts) to phase 1 trials: an evidence based approach. , 7(2), DOI: https://doi.org/10.1016/s1359-6349(09)70470-7.
Article62 days agoFirst-in-human, first-in-class, phase I study of a human monoclonal antibody CNTO 888 to the CC-chemokine ligand 2 (CCL2/MCP-1) in patients with solid tumors
Shahneen Sandhu, Peter C.C. Fong, Sophia Frentzas, Amita Patnaik, K. Papadopoulos, Brenda Tromp, Thomas A. Puchalski, Birge Berns, Anthony W. Tolcher, Johann S. de Bono (2009). First-in-human, first-in-class, phase I study of a human monoclonal antibody CNTO 888 to the CC-chemokine ligand 2 (CCL2/MCP-1) in patients with solid tumors. , 27(15_suppl), DOI: https://doi.org/10.1200/jco.2009.27.15_suppl.e13500.
Article62 days agoTreatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer
Martin Förster, Konstantin J. Dedes, Shahneen Sandhu, Sophia Frentzas, Rebecca Kristeleit, Alan Ashworth, Christopher Poole, Britta Weigelt, Stan B. Kaye, L Rhoda Molife (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. , 8(5), DOI: https://doi.org/10.1038/nrclinonc.2011.42.
Article62 days agoFirst-in-human, first-in-class, phase I study of a human monoclonal antibody CNTO 888 to the CC-chemokine ligand 2 (CCL2/MCP-1) in patients with solid tumors
Shahneen Sandhu, Peter C.C. Fong, Sophia Frentzas, Amita Patnaik, K. Papadopoulos, Brenda Tromp, Thomas A. Puchalski, Birge Berns, Anthony W. Tolcher, Johann S. de Bono (2009). First-in-human, first-in-class, phase I study of a human monoclonal antibody CNTO 888 to the CC-chemokine ligand 2 (CCL2/MCP-1) in patients with solid tumors. , 27(15_suppl), DOI: https://doi.org/10.1200/jco.2009.27.15_suppl.e13500.
Article62 days ago